LUPPI, Mario

	Titolo	Data di pubblicazione	Autore(i)
1	β-HHVs and HHV-8 in Lymphoproliferative Disorders.	2011	C. Quadrelli ;P. Barozzi;G. Riva;D. Vallerini ;E. Zanetti; L. Potenza ;F. Forghieri ;M. LUPPI
2	Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma)	2008	P. Barozzi; G. Riva; B. Ruozi; G. Tosi; D. Belletti; L. Potenza; C. Quadrelli; D. Vallerini; E. Zanetti; M. Morselli; F. Forghieri; M. Maccaferri; A. Paolini; F. Volzone; M.A. Vandelli; F. Forni; G. Torelli; M. Luppi
3	Variability of Voriconazole Trough Levels in Haematological Patients: Influence of Comedications with cytochrome P450(CYP) Inhibitors and/or with CYP Inhibitors plus CYP Inducers	2016	Cojutti, Piergiorgio; Candoni, Anna; Forghieri, Fabio; Isola, Miriam; Zannier, Maria Elena; Bigliardi, Sara; Luppi, Mario; Fanin, Renato; Pea, Federico
4	Variability and evolution of Kaposi's sarcoma-associated herpesvirus in Europe and Africa. International Collaborative Group.	1999	Cook PM; Whitby D; Calabro ML; Luppi M; Kakoola DN; Hjalgrim H; Ariyoshi K; Ensoli B; Davison AJ; Schulz TF.
5	Use of a high sensitive nanofluidic array for the detection of rare copies of BCR-ABL1 transcript in patients with Philadelphia-positive acute lymphoblastic leukemia in complete response	2014	Iacobucci, Ilaria; Lonetti, Annalisa; Venturi, Claudia; Ferrari, Anna; Papayannidis, Cristina; Ottaviani, Emanuela; Abbenante, Maria Chiara; Paolini, Stefania; Bresciani, Paola; Potenza, Leonardo; Parisi, Sarah; Cattina, Federica; Soverini, Simona; Russo, Domenico; Luppi, Mario; Martinelli, Giovanni
6	An unusual case of splenomegaly and increased lactate dehydrogenase heralding acute myeloid leukemia with eosinophilia and RUNX1-MECOM fusion transcripts	2014	Forghieri, Fabio; Bigliardi, Sara; Morselli, Monica; Potenza, Leonardo; Fantuzzi, Valeria; Faglioni, Laura; Nasillo, Vincenzo; Messerotti, Andrea; Paolini, Ambra; Luppi, Mario
7	An unusual case of B-ALL occurring in a patient with acute promyelocytic leukemia in remission after two hematopoietic SCTs: whose are the leukemic cells?	2014	Bigliardi, S; Morselli, M; Potenza, L; Bresciani, P; Cuoghi, A; Coluccio, V; Riva, G; Paolini, A; Fantuzzi, V; Faglioni, L; Nasillo, V; Messerotti, A; Marasca, R; Narni, F; Luppi, M; Forghieri, F
8	A typical atypical chronic myeloid leukemia	2018	Gilioli, Andrea; Paolini, Ambra; Bonacorsi, Goretta; Luppi, Mario
9	Tumor-targeted immunoliposomal nanosystems to deliver either Cidofovir or Antineoplastic SiRNA against Primary Effusion Lymphoma (PEL)	2011	Riva G; Belletti D; Ruozi B; Barozzi P; Vallerini D; Quadrelli C; Zanetti E; Morselli M; Forghieri F; Marasca R; Narni F; Tosi G; Forni F; Vandelli MA; Potenza L; Luppi M
10	Trends in immune cell function assay and donor-specific HLA antibodies in kidney transplantation: A 3-year prospective study	2013	Libri, I; Gnappi, E; Zanelli, P; Reina, M; Giuliodori, S; Vaglio, A; Palmisano, A; Buzio, C; Riva, G; Barozzi, P; Luppi, M; Cravedi, P; Maggiore, U
11	Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir	2005	Luppi M; Trovato R; Barozzi P; Vallisa D; Rossi G; Re A; Ravazzini L; Potenza L; Riva G; Morselli M; Longo G; Cavanna L; Roncaglia R; Torelli G
12	Translational challenges of human herpesvirus 6 chromosomal integration.	2010	Potenza, Leonardo; Barozzi, Patrizia; Torelli, G; Luppi, Mario
13	Thrombotic complications associated with thalidomide in multiple myeloma: an old problem with new questions and quandaries in decision-making	2004	Potenza L; Luppi M; Morselli M; Saviola A; Ferrari A; Riva G; Longo G; Marietta M; Torelli G
14	Three- or four-factor prothrombin complex concentrate for emergency anticoagulation reversal: what are we really looking for?	2011	Marietta M;Pedrazzi P;Luppi M
15	THE USE OF CYCLOSPORINE-A IN THE TREATMENT OF B-CHRONIC LYMPHOCYTIC-LEUKEMIA - replay	1995	EMILIA G; MESSORA C; BENSI L; LUPPI M
16	The therapeutic response and clinical outcome of adults with ALL1(MLL)/AF4 fusion positive acute lymphoblastic leukemia according to the GIMEMA experience.	2010	Cimino, G; Cenfra, N; Elia, L; Sica, S; Luppi, Mario; Meloni, G; Vignetti, M; Paoloni, F; Foà, R; Mandelli, F.
17	The new lymphotropic herpesviruses (HHV-6, HHV-7, HHV-8) and hepatitis C virus (HCV) in human lymphoproliferative diseases: An overview	1996	Luppi M; Torelli G
18	The human A-myb protein is a strong activator of transcription	1994	Golay J; Loffarelli L; Luppi M; Castellano M; Introna M.
19	Targeting neoplastic B cells and harnessing microenvironment: the “double face” of ibrutinib and idelalisib	2015	Maffei, Rossana; Fiorcari, Stefania; Martinelli, Silvia; Potenza, Leonardo; Luppi, Mario; Marasca, Roberto
20	Suppressive effect of human herpesvirus-8/Kaposi sarcoma-associated herpesvirus on in vitro colony formation of hematopoietic progenitor cells	2005	Luppi M; Trovato R; Barozzi P; Gibellini F; Potenza L; Riva G; Torelli G